Fiche publication
Date publication
avril 2026
Journal
Expert review of clinical immunology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Massironi S, Fanizzi F, Invernizzi F, Furfaro F, Ciocca L, Arcari I, Allocca M, Peyrin-Biroulet L, Danese S
Lien Pubmed
Résumé
Primary sclerosing cholangitis (PSC) represents a progressive fibroinflammatory cholangiopathy intricately linked to inflammatory bowel disease (IBD), forming a distinctive overlap syndrome driven by immune dysregulation and gut - liver axis disruption and characterized by a markedly increased risk of colorectal and hepatobiliary cancers.
Mots clés
Crohn’s disease, PSC-IBD, Primary sclerosing cholangitis, advanced therapies, gut-liver axis, inflammatory bowel diseases, ulcerative colitis
Référence
Expert Rev Clin Immunol. 2026 04 22;:
